(E)-2-(3,4-dimethoxyphenyl)-4-(pyridin-3-ylmethylene)oxazol-5(4H)-one manufacturers
- DAPK-IN-2
-
- $58.00
-
2026-08-08
- CAS:304000-05-3
- Purity: 98.26%
- Supply Ability: 10g
|
| | (E)-2-(3,4-dimethoxyphenyl)-4-(pyridin-3-ylmethylene)oxazol-5(4H)-one Basic information |
| Product Name: | (E)-2-(3,4-dimethoxyphenyl)-4-(pyridin-3-ylmethylene)oxazol-5(4H)-one | | Synonyms: | (E)-2-(3,4-dimethoxyphenyl)-4-(pyridin-3-ylmethylene)oxazol-5(4H)-one;WAY-380496;2-(3,4-Dimethoxyphenyl)-4-(3-pyridinylmethylene)-5(4H)-oxazolone;5(4H)-Oxazolone, 2-(3,4-dimethoxyphenyl)-4-(3-pyridinylmethylene)-;DAPK-IN-2;2-(3,4-Dimethoxyphenyl)-4-(pyridin-3-ylmethylene)oxazol-5(4H)-one;2-(3,4-dimethoxyphenyl)-4-[(pyridin-3-yl)methylidene]-4,5-dihydro-1,3-oxazol-5-one | | CAS: | 304000-05-3 | | MF: | C17H14N2O4 | | MW: | 310.3 | | EINECS: | | | Product Categories: | | | Mol File: | 304000-05-3.mol |  |
| | (E)-2-(3,4-dimethoxyphenyl)-4-(pyridin-3-ylmethylene)oxazol-5(4H)-one Chemical Properties |
| Boiling point | 460.9±55.0 °C(Predicted) | | density | 1.26±0.1 g/cm3(Predicted) | | pka | 3.44±0.12(Predicted) | | form | Solid | | color | Light yellow to yellow |
| | (E)-2-(3,4-dimethoxyphenyl)-4-(pyridin-3-ylmethylene)oxazol-5(4H)-one Usage And Synthesis |
| Uses | DAPK-IN-2 is a DAPK inhibitor. DAPK-IN-2 can be used for the research of cerebral infarction and ischemic diseases[1]. | | References | [1] Okamoto M, et al. Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening. Bioorg Med Chem. 2010;18(7):2728-2734. DOI:10.1016/j.bmc.2010.02.018 |
| | (E)-2-(3,4-dimethoxyphenyl)-4-(pyridin-3-ylmethylene)oxazol-5(4H)-one Preparation Products And Raw materials |
|